Balaxi Pharmaceuticals Ltd Share Price Live
Live Balaxi Pharmaceuticals Share Price Chart
Balaxi Pharmaceuticals Performance
Days Range
| Previous Close | ₹37.71 |
|---|---|
| Open | ₹38.09 |
| Volume | 86,409 |
| Day's Range | ₹36.21 - ₹38.09 |
|---|---|
| 52W Range | ₹35.67 - ₹85.58 |
| Market Cap | ₹208.19 Cr |
Balaxi Pharmaceuticals Fundamentals
| ROCE(TTM) | 7.48 |
|---|---|
| P/E Ratio (TTM) | 14.34 |
| P/B Ratio | 0.87 |
| Industry P/E | 33.34 |
| Debt to Equity | 0.24 |
| ROE | 6.09 |
| EPS (TTM) | 2.63 |
| Dividend Yield | 0 |
| Book Value | 43.12 |
| Face Value | 2 |
| ROCE(TTM) | 7.48 |
|---|---|
| P/E Ratio (TTM) | 14.34 |
| P/B Ratio | 0.87 |
| Industry P/E | 33.34 |
| Debt to Equity | 0.24 |
| ROE | 6.09 |
|---|---|
| EPS (TTM) | 2.63 |
| Dividend Yield | 0 |
| Book Value | 43.12 |
| Face Value | 2 |
Balaxi Pharmaceuticals Financials
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | |
|---|---|---|---|---|
| Net Sales | 73.29 | 76.27 | 70.74 | 56.18 |
| Expenses | 69.78 | 64.17 | 67.06 | 55.49 |
| Profit before tax | 6.07 | 9.66 | 0.90 | 1.38 |
| Operating Profit | 5.36 | 8.64 | 0.29 | 0.21 |
| Net Profit | 5.36 | 8.64 | 0.29 | 0.21 |
| ESP in Rs | 0.97 | 1.56 | 0.05 | 0.04 |
Balaxi Pharmaceuticals Shareholding Pattern
| Held by | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Promoters | 65.99% | 65.99% | 65.99% | 65.99% | 65.99% |
| Flls | 16.48% | 16.48% | 16.02% | 8.87% | 3.5% |
| Dlls | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% |
| Public | 17.5% | 17.5% | 17.96% | 25.12% | 30.49% |
About Balaxi Pharmaceuticals
Balaxi Ventures Limited was formerly incorporated in the name of 'The Anandam Rubber Company Limited' on September 28, 1942. The Company changed its name from 'The Anandam Rubber Company Limited' to 'Balaxi Ventures Limited' on August 08, 2017. The Company incorporated with a basic objective of running rubber and tea plantations and owns several plantations across South India.
In year 1989 the company sold its entire plantations to meet the emerging business needs and started concentrating in Investments and trading. The company previously was a investment company, but the company during the financial year 2018-19 has commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG Products
On 15 March 2017, Balaxi Overseas Private Limited (BOPL) entered into a Share Purchase Agreement (SPA) with the erstwhile promoters of Company (i.e. Mr. Nirej V. Paul, Mr. V. M. Paulose, Dr. Leelamma T. J and Mrs. Jaya Paul) to acquire 1,670,036 Equity Shares representing 54.94% of the paid up share capital of the Company along with the control over the Company, pursuant to which BOPL made an Open Offer under Regulation 3(1) and Regulation 4 of SEBI (SAST) Regulations, 2011. Control and management of the Company was acquired by BOPL on May 04, 2017 and it became the new promoter of Company and their representatives i.e. Mr. Ashish Maheshwari and Mrs. Minoshi Maheshwari became the new Directors of the Company. Simultaneously, erstwhile promoters stepped down as promoters from Company on same day and Mr. Nirej V. Paul and Dr. Leelamma TJ resigned as Managing Director and as Chairperson from the Company, respectively. Under the above said Open Offer, BOPL acquired 3,30,000 equity shares representing 10.86% equity share capital of the Company. On completion of the Open Offer BOPL became the holding and Promoter Company with an aggregate shareholding of 2000036 Equity Shares (ie 65.79%).
The main objects of the company were amended to include activities of International wholesale trading in pharmaceutical, food products and builders' hardware on August 08, 2018. The Company commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG products from Financial Year 2018-19.
Further, in February 2019, it kickstarted Food Products business by launching a range of biscuits under the brand YAP'.
The Company expanded its presence by establishing a central distribution warehouse in Guatemala, marking its entry into the third geography. This expansion helped in strengthening the distribution network and a wider customer base in 2019.
In FY 2023, Company started operations in two Latin American Countries, i.e., Honduras and El Salvador and also started operations in
the Central African Republic.
Parent Organisation
Indian Private
Managing Director
None
Founded
1942
NSE Symbol
BALAXI
Top Mutual Funds Invested in Balaxi Pharmaceuticals Share
Top Mutual Funds Invested in Balaxi Pharmaceuticals Share
| FUND NAME | AUM(%) |
|---|---|
Peer Comparison
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 1,831.1 20.80 (1.15%) | ₹4,34,159.66 | 1,548.0 - 1,910.0![]() |
| Divis Laboratories Ltd | 6,471.0 -19.50 (-0.30%) | ₹1,72,287.78 | 4,955.0 - 7,071.5![]() |
| Torrent Pharmaceuticals Ltd | 3,722.0 -8.40 (-0.23%) | ₹1,26,434.15 | 2,886.45 - 3,882.2![]() |
| Cipla Ltd | 1,530.9 5.70 (0.37%) | ₹1,23,148.76 | 1,335.0 - 1,673.0![]() |
| Dr Reddys Laboratories Ltd | 1,257.1 7.80 (0.62%) | ₹1,04,369.38 | 1,020.0 - 1,405.9![]() |
| Lupin Ltd | 2,085.1 13.70 (0.66%) | ₹94,659.39 | 1,795.2 - 2,402.9![]() |
Popular stocks
Balaxi Pharmaceuticals Ltd FAQs
What is the share price of Balaxi Pharmaceuticals Ltd (BALAXI) shares?
Balaxi Pharmaceuticals Ltd (BALAXI) share price as of November 28, 2025, on NSE is Rs 36.75 (NSE) and Rs 36.75 (BSE) on BSE.
Can I buy Balaxi Pharmaceuticals Ltd (BALAXI) from Angel One?
Yes, You can buy Balaxi Pharmaceuticals Ltd (BALAXI) shares by opening a Demat account with Angel One.
How do I buy Balaxi Pharmaceuticals Ltd (BALAXI) from Angel One?
Balaxi Pharmaceuticals Ltd (BALAXI) share can be bought through the following modes:
1. Direct investment: You can buy Balaxi Pharmaceuticals Ltd (BALAXI) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Balaxi Pharmaceuticals Ltd (BALAXI) shares.
1. Direct investment: You can buy Balaxi Pharmaceuticals Ltd (BALAXI) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Balaxi Pharmaceuticals Ltd (BALAXI) shares.




